NOA rizatriptan (as benzoate) 5 mg orodispersible tablet blister pack

국가: 오스트레일리아

언어: 영어

출처: Department of Health (Therapeutic Goods Administration)

유효 성분:

rizatriptan benzoate, Quantity: 7.265 mg (Equivalent: rizatriptan, Qty 10 mg)

제공처:

Medis Pharma Pty Ltd

INN (International Name):

rizatriptan benzoate

약제 형태:

Tablet, orally disintegrating

구성:

Excipient Ingredients: colloidal anhydrous silica; microcrystalline cellulose; mannitol; aspartame; calcium silicate; magnesium stearate; crospovidone; Flavour

관리 경로:

Oral

패키지 단위:

2, 6, 3

처방전 유형:

(S4) Prescription Only Medicine

치료 징후:

NOA is indicated for the acute treatment of migraine attacks with or without aura.

제품 요약:

Visual Identification: White, round, flat, bevel-edged tablet embossed with "IZ 5" on one side and plain on the other side; Container Type: Blister Pack; Container Material: PA/Al/PVC/Al - polyamide-aluminium foil-polyvinylchloride/aluminium foil; Container Life Time: 36 Months; Container Temperature: Store below 30 degrees Celsius

승인 상태:

Licence status A

승인 날짜:

2015-02-19